Effects of socioeconomic status and treatment disparities in colorectal cancer survival

被引:172
作者
Le, Hoa [2 ]
Ziogas, Argyrios [1 ,3 ]
Lipkin, Steven M. [1 ,2 ,3 ]
Zell, Jason A. [1 ,2 ,3 ]
机构
[1] Univ Calif Irvine, Dept Epidemiol, Sch Med, Irvine, CA 92697 USA
[2] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Div Hematol Oncol, Irvine, CA 92697 USA
[3] Univ Calif Irvine, Genet Epidemiol Res Inst, Irvine, CA 92697 USA
关键词
D O I
10.1158/1055-9965.EPI-07-2774
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Poor survival among colorectal cancer (CRC) cases has been associated with African-American race and low socioeconomic status (SES). However, it is not known whether the observed poor survival of African-American CRC cases is due to SES itself and/or treatment disparities. We set out to determine this using data from the large, population-based California Cancer Registry database. Methods: A case-only analysis of CRC was conducted including all age groups using California Cancer Registry data from 1994 to 2003, including descriptive analysis of relevant clinical variables, race, and SES. CRC-specific survival univariate analyses were conducted using the Kaplan-Meier method. Multivariate survival analyses were done using Cox proportional hazards ratios (HR). Results: Incident cases of colon (90,273) and rectal (37,532) cancer were analyzed, including 91,739 (71.8%) non-Hispanic Whites, 8,535 (6.7%) African-Americans, 14,943 (11.7%) Hispanics, 3,564 (2.8%) Chinese, and 7,950 (6.2%) non-Chinese Asians. African-Ameri cans had a greater proportion of metastatic stage at presentation (P < 0.0001) and decreased CRC-specific survival (P < 0.0001 for colon and rectal cancer). After adjustment for age, sex, histology, site within the colon, and stage, African-Americans [colon: HR, 1.19; 95% confidence interval (95% CI), 1.14-1.25; rectum: HR, 1.27; 95% Cl, 1.17-1.38] had an increased risk of death compared with Caucasians. However, after further adjustment for SES and treatment, the risk of death for African-Americans compared with Caucasians was substantially diminished (colon: HR, 1.08; 95% CI, 1.03-1.13; rectum: HR, 1.11; 95% CI, 1.02-1.20). Conclusion: Among CRC cases, disparities in treatment and SES largely explain the observed decreased survival of African-Americans, underscoring the importance of health disparity research in this disease.
引用
收藏
页码:1950 / 1962
页数:13
相关论文
共 66 条
[1]   Barriers to the participation of African-American patients with cancer in clinical trials - A pilot study [J].
Advani, AS ;
Atkeson, B ;
Brown, CL ;
Peterson, BL ;
Fish, L ;
Johnson, JL ;
Gockerman, JP ;
Gautier, M .
CANCER, 2003, 97 (06) :1499-1506
[2]   Colorectal cancer in African Americans [J].
Agrawal, S ;
Bhupinderjit, A ;
Bhutani, MS ;
Boardman, L ;
Nguyen, C ;
Romero, Y ;
Srinvasan, R ;
Figueroa-Moseley, C .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (03) :515-523
[3]   High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas [J].
Alexander, D ;
Jhala, N ;
Chatla, C ;
Steinhauer, J ;
Funkhouser, E ;
Coffey, CS ;
Grizzle, WE ;
Manne, U .
CANCER, 2005, 103 (10) :2163-2170
[4]   Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinoma [J].
Alexander, D ;
Chatla, C ;
Funkhouser, E ;
Meleth, S ;
Grizzle, WE ;
Manne, U .
CANCER, 2004, 101 (01) :66-76
[5]  
[Anonymous], J NATL CANC I MONOGR
[6]   Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort [J].
Ayanian, JZ ;
Zaslavsky, AM ;
Fuchs, CS ;
Guadagnoli, E ;
Creech, CM ;
Cress, RD ;
O'Connor, LC ;
West, DW ;
Allen, ME ;
Wolf, RE ;
Wright, WE .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (07) :1293-1300
[7]   Explaining black-white differences in receipt of recommended colon cancer treatment [J].
Baldwin, LM ;
Dobie, SA ;
Billingsley, K ;
Cai, Y ;
Wright, GE ;
Dominitz, JA ;
Barlow, W ;
Warren, JL ;
Taplin, SH .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (16) :1211-1220
[8]   Treatment differences between blacks and whites with colorectal cancer [J].
Ball, JK ;
Elixhauser, A .
MEDICAL CARE, 1996, 34 (09) :970-984
[9]  
*CAL DEP HLTH SERV, 1998, CAL CANC REP SYST ST, V4
[10]  
*CAL DEP HLTH SERV, 1997, CAL CANC REP SYST ST, V3